Stoke Therapeutics STOK
NASDAQ STOK
$26.00 +0.12 (+0.46%)
At close: Sep 30, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Capital Expenditures (2018 - 2026)

Updated

Stoke Therapeutics (STOK) posted Capital Expenditures of $1.98 million for Q2 2026, compared with $154,000 a year earlier and up 459.8% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Capital Expenditures (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Stoke Therapeutics was $2.69 million, up 497.1% year-over-year; for FY2025, it was $670,000, up 230.0% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of -8.6% (FY2020 to FY2025).
  • In prior years, Stoke Therapeutics' Capital Expenditures was $203,000 in FY2024 (-87.4%), $1.62 million in FY2023 (-59.2%), $3.96 million in FY2022 (+230.2%) and $1.2 million in FY2021 (+14.3%).
  • The Q2 2026 figure stands as the highest quarterly Capital Expenditures since Q3 2022.
  • On a year-over-year basis, Capital Expenditures increased in four of the last six quarters, with growth averaging 115.5%.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2022, with growth of 643.6%; the weakest was Q2 2024, with a decline of 94.5%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $353,000 (Q1 2026), $232,000 (Q4 2025) and $132,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Stoke Therapeutics 1.61 Bn 445.64 Mn - 1.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.98 Mn
Mar 31, 2026 353,000.00
Dec 31, 2025 232,000.00
Sep 30, 2025 132,000.00
Jun 30, 2025 154,000.00
Mar 31, 2025 152,000.00
Dec 31, 2024 42,000.00
Sep 30, 2024 103,000.00
Jun 30, 2024 46,000.00
Mar 31, 2024 12,000.00
Dec 31, 2023 229,000.00
Sep 30, 2023 383,000.00
Jun 30, 2023 839,000.00
Mar 31, 2023 165,000.00
Dec 31, 2022 409,000.00
Sep 30, 2022 2.03 Mn
Jun 30, 2022 682,000.00
Mar 31, 2022 841,000.00
Dec 31, 2021 203,000.00
Sep 30, 2021 273,000.00
API Access

Stoke Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=STOK&period=max&api_key=YOUR_API_KEY